Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment
Clinical and Experimental Hepatology · 2020 · 6 (3) · 170-175
DOI: 10.5114/ceh.2020.99506 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Clinical and Experimental Hepatology, 2020. Verfasst von Wojciech Straś und 2 weiteren Autor:innen. Beteiligte Einrichtung: Bluefish Pharma Sp. z o.o., Warsaw, Poland. Die Arbeit wurde bisher 12-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Bluefish Pharma Sp. z o.o., Warsaw, Poland.
- Medical University of Warsaw, Poland.
Zitieren
APA
Straś, W., Małkowski, P., & Tronina, O. (2020). Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment. Clinical and Experimental Hepatology, 6(3), 170-175. https://doi.org/10.5114/ceh.2020.99506
Vancouver
Straś W, Małkowski P, Tronina O. Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment. Clinical and Experimental Hepatology. 2020;6(3):170-175. doi:10.5114/ceh.2020.99506
BibTeX
@article{Stra2020,
author = {Straś, Wojciech and Małkowski, Piotr and Tronina, Olga},
title = {Hepatocellular carcinoma in patients with non-alcoholic steatohepatitis – epidemiology, risk factors, clinical implications and treatment},
journal = {Clinical and Experimental Hepatology},
year = {2020},
volume = {6},
number = {3},
pages = {170--175},
doi = {10.5114/ceh.2020.99506}
}
EUVIMED